Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Wehrhahn

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Journal of Infectious Diseases|April 12, 2012
Illness severity in community-onset invasive Staphylococcus aureus infection and the presence of virulence genesMichael C Wehrhahn, J Owen Robinson, Elaine M Pascoe, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 16, 2010
Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case-control studyM C Wehrhahn, J O Robinson, J C Pearson, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 26, 2021
An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian populationMichael C Wehrhahn, Suzanne J Brown, James P Newcombe, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2015
Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14Daniel R Knight, Steven Giglio, Peter G Huntington, et al.
Journal of Clinical Microbiology|August 28, 2020
Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018Stacey Hong, Papanin Putsathit, Narelle George, et al.
The Journal of Antimicrobial Chemotherapy|April 25, 2021
Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18Papanin Putsathit, Stacey Hong, Narelle George, et al.
Frontiers in Cellular and Infection Microbiology|March 11, 2026
Metagenomics enables parallel detection of 176 clinically relevant targets from faecal samplesDonovan H Parks, Rhys J P Newell, Andrew N Ginn, et al.
Microbial Genomics|May 8, 2024
Defining the phylogenetics and resistome of the major <i>Clostridioides difficile</i> ribotypes circulating in AustraliaKeeley O'Grady, Stacey Hong, Papanin Putsathit, et al.
The Journal of Infectious Diseases|March 20, 2026
Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant Mycoplasma pneumoniae in Australia During the 2023-2024 EpidemicKingsley King-Gee Tam, Carl J E Suster, Winkie Fong, et al.
The Lancet. Microbe|February 28, 2026
Characterisation of Bordetella pertussis virulence and macrolide resistance in Australia by targeted culture-independent sequencing: a genomic epidemiology studyWinkie Fong, Rebecca J Rockett, Kingsley King-Gee Tam, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Infectious Diseases|April 12, 2012
Illness severity in community-onset invasive Staphylococcus aureus infection and the presence of virulence genesMichael C Wehrhahn, J Owen Robinson, Elaine M Pascoe, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 16, 2010
Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case-control studyM C Wehrhahn, J O Robinson, J C Pearson, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 26, 2021
An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian populationMichael C Wehrhahn, Suzanne J Brown, James P Newcombe, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2015
Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14Daniel R Knight, Steven Giglio, Peter G Huntington, et al.
Journal of Clinical Microbiology|August 28, 2020
Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018Stacey Hong, Papanin Putsathit, Narelle George, et al.
The Journal of Antimicrobial Chemotherapy|April 25, 2021
Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18Papanin Putsathit, Stacey Hong, Narelle George, et al.
Frontiers in Cellular and Infection Microbiology|March 11, 2026
Metagenomics enables parallel detection of 176 clinically relevant targets from faecal samplesDonovan H Parks, Rhys J P Newell, Andrew N Ginn, et al.
Microbial Genomics|May 8, 2024
Defining the phylogenetics and resistome of the major <i>Clostridioides difficile</i> ribotypes circulating in AustraliaKeeley O'Grady, Stacey Hong, Papanin Putsathit, et al.
The Journal of Infectious Diseases|March 20, 2026
Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant Mycoplasma pneumoniae in Australia During the 2023-2024 EpidemicKingsley King-Gee Tam, Carl J E Suster, Winkie Fong, et al.
The Lancet. Microbe|February 28, 2026
Characterisation of Bordetella pertussis virulence and macrolide resistance in Australia by targeted culture-independent sequencing: a genomic epidemiology studyWinkie Fong, Rebecca J Rockett, Kingsley King-Gee Tam, et al.
Pageof 6